Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy

This study has been completed.
Sponsor:
Collaborator:
Napoli CTO Hospital
Information provided by:
Second University of Naples
ClinicalTrials.gov Identifier:
NCT01025934
First received: December 3, 2009
Last updated: NA
Last verified: December 2009
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given
No publications provided by Second University of Naples

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):